Area of research
Surgery · Transplantation
Research interest
Research interests include Medicine, Transplantation, Internal medicine, Lung transplantation, Lung, and Heart transplantation.
Outcomes After Donation After Circulatory Determination of Death Cardiac Transplantation
Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure
Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction
Fifty Year Outcomes After Pediatric Heart Transplantation: A Pediatric-Adult Center Linked Analysis
Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease
Just a number? Donor age and (lack of) associated reasons for heart offer refusal
Non-Invasive Characterization and Early Detection of Post-Transplant Lymphoproliferative Disorders
Updates from the International Consortium on Primary Graft Dysfunction: An Interim Report and Important Themes
Association Between De Novo Donor Specific Antibodies and Baseline Lung Allograft Dysfunction
A Molecular Criteria for Antibody Mediated Rejection in Lung Transplant Recipients is Associated with an Increased Risk of the Composite Outcome of CLAD and Death
Plasma Cell-Free DNA Chromatin Immunoprecipitation Distinguishes Acute Rejection Subtypes After Heart Transplantation
Left Ventricular Dysfunction Associated With Brain Death: Results From the Donor Heart Study
Preemptive treatment of de novo donor-specific antibodies in lung transplant patients reduces subsequent risk of chronic lung allograft dysfunction or death
2731. Posa-bly the Better Option? Comparison of Posaconazole vs. Itraconazole for Antifungal Prophylaxis After Heart Transplantation
Combining donor derived cell free DNA and gene expression profiling for non‐invasive surveillance after heart transplantation
Tumor Microenvironment Determinants of Immunotherapy Response Identified By Integrated Host & Viral Analysis of Post-Transplant Lymphoproliferative Disorders
Keep Your Cool! One Year Outcomes with Use of a Hypothermic Preservation System Compared to Standard Storage with Ice During Heart Procurement
Very Temporary Mechanical Support Prior to Heart Transplant: Post-Transplant Outcomes as Status 1-2 versus 3-6 in the Setting of Short Wait Times
Impact of AMR Treatment: Responders vs Non-Responders Characteristics
Donor-derived, cell-free DNA levels by next-generation targeted sequencing are elevated in allograft rejection after lung transplantation
Recent Trends of Infectious Complications Following Heart Transplantation
Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation
Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation
Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis
The role of complement‐fixing donor‐specific antibodies identified by a C1q assay after heart transplantation
Early Graft Injury Measured by Donor-Derived Cell-Free DNA Predicts Early Mortality in Lung Transplant Recipients
Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma
Noninvasive monitoring of infection and rejection after lung transplantation
Monitoring Pharmacologically Induced Immunosuppression by Immune Repertoire Sequencing to Detect Acute Allograft Rejection in Heart Transplant Patients: A Proof-of-Concept Diagnostic Accuracy Study
Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection